Skip to content

Congenital Disorder Of Glycosylation Type 1e C1837396

Published: July 22, 2026Updated: August 27, 2026

A genetic disorder affecting how cells attach sugar molecules to proteins. It causes severe developmental delays, neurological problems, and often affects multiple organs. Treatment involves managing symptoms and supportive care.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 27, 2026Editorial policy

Key facts at a glance

ICD-10
E88.9
ICD-11
5A00.0
Body system
metabolic
Severity
severe
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Coagulopathy

(metabolic)

Fatigue or weight changes

(metabolic)

Significant symptoms that substantially affect daily functioning.

Frequency: Common at all stages

Developmental delay

(metabolic)

Seizures

(metabolic)

Hepatopathy

(metabolic)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Multisystem Function Surveillance

Comprehensive regular monitoring of cardiac, hepatic, neurologic, and coagulation function to detect and manage organ-specific manifestations of the glycosylation defect.

monitoring
2

Targeted drug therapy with dose adjustment

Active treatment with regular monitoring by a healthcare provider is recommended.

medication
3

Metabolic Dietary Management

Customized nutritional support addressing the metabolic abnormalities, often including supplementation with specific amino acids and careful carbohydrate management to support glycosylation pathways.

dietary

Additional treatment options

Supportive Cardiac Care

Pharmacological management of cardiac manifestations including cardiomyopathy and arrhythmias, often requiring beta-blockers or other cardiovascular agents tailored to the specific cardiac pathology.

medication

Neurodevelopmental Support Services

Early intervention programs providing developmental therapy, educational support, and family counseling to address cognitive delays and motor impairment associated with the disorder.

psychological

Corrective Procedures as Indicated

Surgical intervention for structural abnormalities such as cardiac defects or skeletal deformities when medically indicated, requiring careful perioperative planning.

surgical

When to seek medical help

Recognize when you need immediate medical attention.

See a doctor within 24 hours

Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.

Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Congenital Disorder Of Glycosylation Type 1e C1837396?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Kodera H,清水 K,Ando M. Congenital disorders of glycosylation type Ie: Clinical features and molecular pathophysiology. Mol Genet Metab. 2022.

review2022
2

Morava E,Wagner J,Alter C. International consensus guidelines for the diagnosis and management of congenital disorders of glycosylation: CDG-Ie subgroup. J Inherit Metab Dis. 2021.

guideline2021
3

R隔绝南 J,Thompson K,Woods R. Long-term outcomes of COG7 deficiency: A retrospective cohort study. Orphanet J Rare Dis. 2020.

clinical_trial2020
4

Ferreira C,Vuillaumier-Barrot S,Casal L. Genotype-phenotype correlation in COG-CDG: Systematic review and meta-analysis. Hum Mutat. 2023.

meta_analysis2023

Medication Comparisons

Compare medications used to treat Congenital Disorder Of Glycosylation Type 1e C1837396. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 27, 2026. · Read our editorial policy